 Changes in β-adrenoceptor (G-protein coupled) density and affinity in the heart, lung and brain have been associated with a variety of disorders, such as myocardial ischemia and infarction, congestive heart failure, asthma, chronic obstructive pulmonary disease, depression, schizophrenia, and Alzheimer’s disease (1-3). There are at least four subtypes of β-adrenoceptor receptors: β